scorecardresearch
Monday, August 18, 2025
TopicSerum Institute India

Topic: Serum Institute India

After public spat, Bharat Biotech & SII jointly pledge smooth roll out of Covid vaccines

The joint statement comes after Bharat Biotech MD Dr Krishna Ella hit out at Serum CEO Adar Poonawalla’s comment that only Pfizer, Moderna, Oxford vaccines were effective.

Serum Institute, Bharat Biotech, Cadila vaccines — sifting science from non-science

In episode 653 of ‘Cut The Clutter’, the first in the new year, ThePrint’s Editor-in-Chief Shekhar Gupta explained working of Covaxin, Covishield & Zydus Cadila’s DNA vaccine.

Respect govt decision to bar Covishield export, expect nod in March-April, says Serum CEO

Adar Poonawalla, CEO of Serum Institute of India, says the govt restrictions ‘will be eased out very soon once the most vulnerable population starts getting vaccinated’.

DCGI’s Covaxin ‘approval’ is political jumla. It reinforces idea of Modi’s Atmanirbhar Bharat

The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.

Oxford vaccine to cost Rs 219-292 to govt, double for private buyers, says Adar Poonawalla

The Serum Institute of India CEO said Covishield will be sold to the govt and Global Alliance for Vaccines and Immunization countries first and on the private market later.

Serum expects govt to sign pricing deal for Covishield within days

Officials have 'indicated orally' that first 100mn vaccines will be purchased at Rs 200 & a deal should be inked 'in next one or two days', according to Serum CEO Adar Poonawalla.

Everything we know about Covishield, one of 2 Covid vaccines likely to get nod for use in India

Covishield is Serum Institute of India’s version of the Oxford-AstraZeneca vaccine that had been in the works for several months.

Health Minister Vardhan launches India’s first indigenous pneumococcal vaccine Pneumosil

Pneumosil, developed by SII in collaboration with partners like Bill and Melinda Gates Foundation, will be available at an affordable price, the health ministry said.

Serum Institute has produced 40-50 million doses of Covishield vaccine, says Adar Poonawalla

The Serum Institute CEO also said the vaccine rollout is expected to be slow in the initial phase due to some logistics issues and is expected to pick up once things get sorted.

Govt looks into new vaccine data after Pfizer, Bharat Biotech, SII seek emergency use approval

Govt had sought additional data on the vaccine candidates of companies seeking emergency use authorisation. So far, just one company has submitted this information.

On Camera

Why Modi, BJP should worry about bad blood between CEC Gyanesh Kumar and Rahul Gandhi

If there is bad blood between the CEC and the Opposition leaders, it will shake the people’s faith in election results. It’s the worst thing that could happen to Indian democracy.

Navigating Trump’s tariffs is no child’s play. Indian toymakers are losing out on orders, enquiries

Indian toymakers are now exploring new markets, but they want govt to negotiate a trade deal with US soon, introduce incentives and subsidies to make the industry more competitive.

Chinese FM Wang Yi in India, here’s what’s on top of agenda for talks between New Delhi & Beijing

New Delhi: De-escalation of troops in the icy heights of eastern Ladakh, restarting of patrolling in key areas along the Line of Actual Control...

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?